PROF

Profound Medical Corp

Feb 25 • 04:00PM ET

7.40

+0.25 3.50 %

Healthcare • Medical Devices • Canada • NASD

Peers: ISRG BSX INMD BDX HOLX CLPT EDAP ATEC CUTR NUWE

Index	-	P/E	-	EPS (ttm)	-1.34	Insider Own	6.01%	Shs Outstand	36.29M	Perf Week	5.41%
Market Cap	268.55M	Forward P/E	-	EPS next Y	-0.96	Insider Trans	0.00%	Shs Float	34.11M	Perf Month	-5.13%
Enterprise Value	248.48M	PEG	-	EPS next Q	-0.27	Inst Own	42.93%	Short Float	3.85%	Perf Quarter	23.13%
Income	-39.34M	P/S	18.78	EPS this Y	-21.87%	Inst Trans	14.22%	Short Ratio	7.26	Perf Half Y	58.46%
Sales	14.30M	P/B	6.95	EPS next Y	29.67%	ROA	-93.45%	Short Interest	1.31M	Perf YTD	-5.97%
Book/sh	1.06	P/C	10.82	EPS next 5Y	15.12%	ROE	-125.17%	52W High	8.95 -17.32%	Perf Year	4.23%
Cash/sh	0.68	P/FCF	-	EPS past 3/5Y	9.19% 3.91%	ROIC	-122.40%	52W Low	3.76 96.81%	Perf 3Y	-41.50%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	15.83% 20.72%	Gross Margin	75.65%	Volatility	4.87% 7.17%	Perf 5Y	-65.69%
Dividend TTM	-	EV/Sales	17.38	EPS Y/Y TTM	1.23%	Oper. Margin	-295.35%	ATR (14)	0.47	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.34	Sales Y/Y TTM	67.95%	Profit Margin	-275.16%	RSI (14)	55.92	Recom	1.20
Dividend Gr. 3/5Y	- -	Current Ratio	4.18	EPS Q/Q	30.57%	SMA20	6.87%	Beta	0.63	Target Price	12.35
Payout	-	Debt/Eq	0.15	Sales Q/Q	86.76%	SMA50	-0.80%	Rel Volume	0.64	Prev Close	7.15
Employees	142	LT Debt/Eq	0.00	Earnings	Mar 05 AMC	SMA200	22.43%	Avg Volume	180.66K	Price	7.40
IPO	Jun 09, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	30.11% 6.30%	Trades		Volume	115,426	Change	3.50%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-23-24	Initiated	Lake Street	Buy	$16.50
Jul-16-24	Upgrade	Stifel	Hold → Buy	$9 → $12
Nov-28-23	Initiated	Stifel	Hold	$11
Aug-04-23	Downgrade	Raymond James	Strong Buy → Outperform	$20 → $200
Mar-21-23	Downgrade	Jefferies	Buy → Hold	$5.50 → $10
Sep-15-20	Initiated	Jefferies	Buy

Today 12:15PM	Acadia Healthcare (ACHC) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
Feb-12-26 04:30PM	Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th - Conference Call to Follow (GlobeNewswire) +5.94%
08:30AM	Profound Medical Honored with INOVAIT's 2025-2026 Mount Logan Award Recognizing the TULSA Procedure for Prostate Disease (GlobeNewswire)
Feb-05-26 08:00AM	PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve Procedures, Expanding Access to Incision-Free Care for Women's Health (GlobeNewswire) -7.33%
Jan-27-26 04:30PM	Profound Medical Announces Upcoming Investor Events (GlobeNewswire)
08:55AM	Loading…
Jan-16-26 08:55AM	Profound Medical (PROF) Soars 9.5%: Is Further Upside Left in the Stock? (Zacks)
Jan-15-26 09:26AM	Strength Seen in Ocular Therapeutix (OCUL): Can Its 6.1% Jump Turn into More Strength? (Zacks) +9.45%
07:30AM	Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO (GlobeNewswire)
Jan-12-26 08:00AM	Profound Surpasses 2025 TULSA-PRO Installed Base Goal (GlobeNewswire)
Jan-06-26 07:45AM	Johns Hopkins Medicine Treats First Commercial TULSA-PRO Case (GlobeNewswire)
Dec-30-25 04:30PM	Profound Medical Corp. Announces Closing of Private Placement (GlobeNewswire) +7.37%
Dec-24-25 01:15PM	Profound Medical Corp. Announces Upsize of Private Placement (GlobeNewswire)
Dec-23-25 08:00AM	Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th (GlobeNewswire)
Dec-19-25 08:45AM	Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement (GlobeNewswire)
Dec-05-25 09:55AM	Wall Street Analysts Think Profound Medical (PROF) Could Surge 82.37%: Read This Before Placing a Bet (Zacks)
05:00PM	Loading…
Dec-04-25 05:00PM	Stanford Medicine's Dr. Pejman Ghanouni Receives RSNA's Cum Laude Award for CAPTAIN Perioperative Data Presentation (GlobeNewswire)
Nov-28-25 07:45AM	Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO Clinical Data, at RSNA and SUO Meetings (GlobeNewswire)
Nov-24-25 09:55AM	Profound Medical (PROF) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? (Zacks)
09:55AM	Profound Medical (PROF) Just Flashed Golden Cross Signal: Do You Buy? (Zacks)
Nov-19-25 12:00PM	Profound Medical (PROF) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
09:55AM	Wall Street Analysts Believe Profound Medical (PROF) Could Rally 97.59%: Here's is How to Trade (Zacks)
Nov-18-25 04:15PM	Profound Medical Celebrates The Hong Center's 200th Independent TULSA Procedure for Prostate Disease (GlobeNewswire)
Nov-13-25 05:20PM	Profound Medical (PROF) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +7.87%
04:05PM	Profound Medical Reports Strong Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-12-25 08:30AM	Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO to Australia and New Zealand (GlobeNewswire)
07:29AM	Profound Medical Corp (PROF) Q3 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Nov-11-25 04:15PM	Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO and Sonalleve with Al Faisaliah Medical Systems in Saudi Arabia (GlobeNewswire) +7.26%
Nov-10-25 04:30PM	Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO in Canada from Knight (GlobeNewswire)
Oct-16-25 08:00AM	Profound Medical Congratulates the Busch Center for Achieving 500th TULSA Procedure Milestone (GlobeNewswire)
Oct-14-25 08:30AM	Profound Medical to Participate in the Stifel 2025 Healthcare Conference (GlobeNewswire)
07:45AM	Loading…
Oct-07-25 07:45AM	Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter (GlobeNewswire) +11.76%
Sep-23-25 08:00AM	Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment (GlobeNewswire) +17.67%
Aug-28-25 08:00AM	Profound Medical to Participate in Lake Street's 9th Annual Best Ideas Growth Conference (GlobeNewswire)
Aug-15-25 04:25PM	Zevra Therapeutics (ZVRA) Reports Q2 Loss, Tops Revenue Estimates (Revised) (Zacks) -23.29% +11.76%
03:23AM	Profound Medical Corp (PROF) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
Aug-14-25 05:20PM	Profound Medical (PROF) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Profound Medical Announces Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-12-25 05:50PM	Zevra Therapeutics (ZVRA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Aug-07-25 06:35PM	Relay Therapeutics, Inc. (RLAY) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
Aug-05-25 08:15AM	Madrigal (MDGL) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Jul-24-25 05:00PM	Profound Medical to Release Second Quarter 2025 Financial Results on August 14 - Conference Call to Follow (GlobeNewswire)
Jun-25-25 04:09AM	Profound Medical Completes First Commercial BPH Treatment With New TULSA-AI Volume Reduction Module (Insider Monkey)
Jun-10-25 08:00AM	Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO with TULSA-AI Volume Reduction (GlobeNewswire) +17.39%
Jun-04-25 07:45AM	Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO (GlobeNewswire)
May-14-25 04:45PM	Profound Medical Annual General and Special Meeting of Shareholders Voting Results (GlobeNewswire) -5.39% +12.13%
May-09-25 03:40AM	Profound Medical Corp (PROF) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ... (GuruFocus.com) -7.03%
May-08-25 06:20PM	Profound Medical (PROF) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Profound Medical Announces First Quarter 2025 Financial Results (GlobeNewswire)
May-07-25 11:16AM	Profound Medical Corp (TSX:PRN) Q1 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
May-05-25 09:57AM	Strength Seen in Profound Medical (PROF): Can Its 8.3% Jump Turn into More Strength? (Zacks)
Apr-30-25 05:55PM	Profound Medical: In Serious Trouble Despite Projected Growth (Seeking Alpha)
04:30PM	Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference (GlobeNewswire)
Apr-29-25 07:30AM	Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy (GlobeNewswire)
Apr-17-25 08:00AM	Profound Medical to Release First Quarter 2025 Financial Results on May 8 - Conference Call to Follow (GlobeNewswire)
Apr-15-25 07:45AM	Profound Medical AUA 2025 Investor Event Agenda (GlobeNewswire)
Mar-26-25 09:59PM	Wolf Haldenstein Adler Freeman & Herz LLP is investigating Profound Medical Corp. for potential violations of securities laws (GlobeNewswire)
Mar-25-25 08:00AM	Save the Date: Profound Medical to Host Investor Event at AUA 2025 (GlobeNewswire)
Mar-07-25 02:16AM	Profound Medical Corp (PROF) Q4 2024 Earnings Call Highlights: Record Revenue and Improved ... (GuruFocus.com) -5.90%
Mar-06-25 04:05PM	Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-05-25 07:23AM	What To Expect From Profound Medical Corp (TSX:PRN) Q4 2024 Earnings (GuruFocus.com)
Feb-13-25 05:00PM	Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 Conference Call to Follow (GlobeNewswire) +6.52%
Jan-13-25 08:00AM	Update: Profound Medical's Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th (GlobeNewswire)
Jan-08-25 07:30AM	Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues (GlobeNewswire)
Jan-06-25 08:15AM	Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-10-24 09:55AM	Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares (GlobeNewswire)
Dec-06-24 09:31AM	Canadian Investment Regulatory Organization Trade Resumption - PRN (PR Newswire) -6.72%
09:15AM	Canadian Investment Regulatory Organization Trading Halt - PRN (PR Newswire)
09:04AM	Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares (GlobeNewswire)
Dec-05-24 04:48PM	Profound Medical Announces Proposed Public Offering of Common Shares (GlobeNewswire)
Dec-03-24 07:46AM	Profound Medical, Siemens Healthineers enter co-sales, co-marketing agreement (TipRanks)
Dec-02-24 07:30AM	Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy (GlobeNewswire)
Nov-26-24 07:45AM	Profound Medical to Unveil Next TULSA-AI Module, 'UA Alignment Assistant' (GlobeNewswire)
Nov-12-24 08:00AM	Profound Medical to Participate in the Stifel 2024 Healthcare Conference (GlobeNewswire)
Nov-08-24 12:03PM	Profound Medical Corp (PROF) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Rising Expenses (GuruFocus.com)
Nov-07-24 04:05PM	Profound Medical Announces Third Quarter 2024 Financial Results (GlobeNewswire) +12.00%
Nov-06-24 07:41AM	Profound Medical Corp (TSX:PRN) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Nov-04-24 06:55AM	Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025 (GlobeNewswire) +11.56%
Oct-17-24 04:30PM	Profound Medical to Release Third Quarter 2024 Financial Results on November 7 Conference Call to Follow (GlobeNewswire)
Oct-16-24 04:15PM	Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer (GlobeNewswire)
Oct-09-24 05:58PM	Profound Medical Corp (PROF) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amidst ... (GuruFocus.com)
Sep-20-24 08:00AM	iAccess Alpha's Buyside Best Ideas Virtual Fall Conference September 24-25, 2024 (ACCESSWIRE)
Sep-16-24 08:00AM	Profound Medical's PRO-Talk Live! Event Features the Present and Future of TULSA (GlobeNewswire)
Sep-04-24 04:30PM	Profound Medical to Participate in Lake Street's Best Ideas Growth Conference (GlobeNewswire)
Aug-08-24 09:57PM	PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
04:05PM	Profound Medical Announces Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-18-24 04:30PM	Profound Medical to Release Second Quarter 2024 Financial Results on August 8 Conference Call to Follow (GlobeNewswire)
Jul-11-24 07:00AM	Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases (GlobeNewswire)
May-16-24 09:18AM	Profound Medical (PROF) Adds AI to Prostate Cancer Treatment (Zacks)
May-15-24 05:00PM	Profound Medical Annual General Meeting of Shareholders Voting Results (GlobeNewswire)
May-14-24 07:30AM	Profound Medical Receives U.S. FDA 510(k) Clearance for 'Contouring Assistant' AI Module that Enables Creation of an Automated TULSA Treatment Plan (GlobeNewswire) +7.32%
May-13-24 10:46AM	Profound Medical Corp. (NASDAQ:PROF) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 08:55PM	PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace) +13.60% -9.27%
04:05PM	Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance (GlobeNewswire)
May-06-24 04:15PM	Growing Body of Clinical Evidence Points to the Potential of Profound Medical's TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum (GlobeNewswire)
Apr-22-24 04:15PM	Profound Medical to Release First Quarter 2024 Financial Results on May 9 Conference Call to Follow (GlobeNewswire)
Apr-09-24 07:45AM	Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference (GlobeNewswire)
Mar-08-24 03:31PM	Profound Medical Corp. (NASDAQ:PROF) Q4 2023 Earnings Call Transcript (Insider Monkey) -10.86%
Mar-07-24 09:54PM	PROF Stock Earnings: Profound Medical Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace)
04:05PM	Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-04-24 04:30PM	Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference (GlobeNewswire)

Profound Medical Corp. is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the ablation of diseased tissue utilizing its platform technologies. The firm's product, the TULSA-PRO system, combines real-time MRI, robotically driven transurethral sweeping action/thermal ultrasound, and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It is also focused on developing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. The company was founded on June 13, 2008 and is headquartered in Mississauga, Canada.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Menawat Arun Swarup	CEO	May 16 '25	Buy	4.73	12,027	56,888	587,089	May 20 01:56 PM
Menawat Arun Swarup	CEO	May 15 '25	Buy	4.33	10,003	43,263	575,062	May 20 01:56 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PROF

Profound Medical Corp

Upgrade your FINVIZ experience